The global medical device hydrophilic coatings market size is anticipated to reach USD 8,352.8 million by 2033, expanding at a CAGR of 7.5% from 2026 to 2033, according to a new report by Grand View Research, Inc. The industry is driven by the sustained growth in minimally invasive and catheter-based interventions across cardiovascular, neurovascular, and urology specialties, where low-friction performance is critical for procedural efficiency and patient safety. Increasing clinical emphasis on reducing insertion force, minimizing tissue trauma, and improving device trackability, combined with stringent regulatory requirements for biocompatibility and low-VOC formulations, is accelerating adoption of advanced water-based and durable coating systems. Furthermore, the expanding outsourcing trend among OEMs toward specialized coating service providers is strengthening technology integration and recurring demand.
Significant opportunities exist in the development of next-generation multifunctional coatings that integrate hydrophilic, antimicrobial, antithrombotic, or drug-eluting properties, particularly for high-value and implantable devices. Rapid expansion of medical device manufacturing in Asia Pacific, coupled with growing investments in automation and radiation-curable technologies, presents avenues for scalable production and margin expansion. The increasing focus on sustainability and regulatory-compliant chemistries creates strategic growth potential for innovators developing environmentally responsible and high-durability coating platforms.
The water-based segment dominated the medical device hydrophilic coatings market with a 42.0% revenue share in 2025 due to its strong regulatory compliance profile, low VOC emissions, and superior biocompatibility compared to solvent-based alternatives. Its compatibility with polymer substrates widely used in catheters and minimally invasive devices, combined with scalable processing, improved workplace safety, and alignment with sustainability-driven procurement strategies, has made water-based formulations the preferred choice among medical device OEMs and contract coating providers.
Polymers lead the industry due to the widespread use of polymeric materials such as polyurethane, Pebax, PTFE, and nylon in high-volume minimally invasive devices, including catheters, guidewires, and delivery systems. These substrates inherently exhibit higher surface friction and require hydrophilic coatings to enhance lubricity, improve trackability, and reduce tissue trauma, thereby driving substantial and recurring demand for polymer-compatible coating solutions across cardiovascular, neurovascular, and urology applications.
Catheters are used in high volume in cardiovascular, urology, and neurovascular procedures that rely on catheter-based delivery systems, where superior lubricity is essential for smooth navigation through complex anatomies. Hydrophilic coatings significantly reduce insertion force, minimize vessel trauma, and enhance procedural efficiency, making them a critical performance component in catheter design and driving sustained demand across both developed and emerging healthcare markets.
North America dominates the market due to its high concentration of advanced medical device manufacturers, strong procedural volumes in minimally invasive and cardiovascular interventions, and robust healthcare expenditure. The region’s well-established regulatory framework, rapid adoption of next-generation coating technologies, and strong presence of specialized coating providers and OEM partnerships further reinforced its leadership position in terms of revenue generation and technological innovation.
Request a free sample copy or view report summary: Medical Device Hydrophilic Coatings Market Report
Based on formulation, the radiation-curable segment is expected to grow at the fastest CAGR of 7.8% from 2026 to 2033 due to its ability to significantly enhance manufacturing efficiency through rapid curing cycles, lower energy consumption, and improved process control compared to conventional thermal systems. These formulations offer superior coating uniformity, reduced solvent usage, and compatibility with precision and heat-sensitive medical devices, making them increasingly attractive to OEMs seeking scalable, cost-effective, and regulatory-aligned production technologies.
Based on substrate, the polymers segment is expected to grow at a CAGR of 7.5% from 2026 to 2033, driven by the increasing adoption of polymer-based materials in next-generation minimally invasive, flexible, and single-use medical devices. As interventional procedures expand globally, demand for advanced hydrophilic coatings compatible with complex polymer substrates continues to rise, particularly in high-growth applications such as cardiovascular, neurovascular, and urology devices, where enhanced lubricity and biocompatibility are critical performance requirements.
The U.S. is expected to grow at the fastest CAGR of 7.9% from 2026 to 2033, driven by sustained innovation in minimally invasive technologies, strong R&D investments by leading medical device OEMs, and increasing procedural volumes across cardiovascular and neurovascular specialties. The rapid commercialization cycles supported by established regulatory pathways and expanding adoption of advanced, multifunctional coating technologies are accelerating domestic demand for high-performance hydrophilic coating solutions.
Grand View Research has segmented the global medical device hydrophilic coatings market on the basis of formulation, substrate, application, and region:
Medical Device Hydrophilic Coatings Formulation Outlook (Volume Kilotons; Revenue, USD Million, 2018 - 2033)
Water-based
Solvent-based
Radiation-curable
Other Formulations
Medical Device Hydrophilic Coatings Substrate Outlook (Volume Kilotons; Revenue, USD Million, 2018 - 2033)
Polymers
Glass
Metals & Alloys
Other Substrates
Medical Device Hydrophilic Coatings Application Outlook (Volume Kilotons; Revenue, USD Million, 2018 - 2033)
Catheters
Guidewires
Needles
Lenses
Implantable Devices
Other Medical Devices
Medical Device Hydrophilic Coatings Region Outlook (Volume Kilotons; Revenue, USD Million, 2018 - 2033)
North America
U.S.
Canda
Mexico
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
South Africa
List of Key Players in the Medical Device Hydrophilic Coatings Market
Hydromer
dsm-firmenich
Surmodics, Inc.
Freudenberg Medical
Biocoat Incorporated
Harland Medical Systems, Inc.
Innovative Surface Technologies
AST Products, Inc.
Aculon
Joninn ApS
"The quality of research they have done for us has been excellent..."